At Boston IVF, our work doesn’t end with a positive test. Many patients face miscarriage or chromosomal risks, which is why 50% opt for preimplantation genetic testing (PGT) prior to embryo freezing and transfer. As leaders in PGT, we offer advanced testing to identify genetic issues and help individuals achieve their family building goals.
Preimplantation genetic testing (PGT) is one of the most important breakthroughs in the history of reproductive medicine, allowing our physicians and laboratory team to identify genetic or chromosomal defects in an embryo prior to being used in an IVF cycle. These genetic testing technologies have been shown to increase success rates, reduce miscarriage, prevent passing on inherited conditions, and reduce the total time it takes to achieve a live birth.
PGT can be performed on embryos to uncover abnormalities in chromosomal numbers (PGT-Aneuploidy) or to discover which embryos are affected or not affected by a gene mutation (PGT-M).
If you are:
An IVF patient of over 35, whose increased age is a risk factor for chromosomal abnormalities
A carrier of or affected by a monogenic genetic disorder (e.g. cystic fibrosis)
And want to:
Increase your chance of a successful embryo transfer and/or decrease your risk of miscarriage or chromosomal disorder in your baby
Eliminate the chance of passing it on to your children
Looks for:
Abnormalities in the number of chromosomes
Mutations in a specific, single gene on a chromosome
Tells us:
Whether an embryo has the correct number of chromosomes or not and the sex of an embryo
Whether an embryo is affected by a certain genetic disorder
You're close to/over the age of 40
You've had multiple unsuccessful IVF cycles
You've experienced recurrent miscarriages
You wish to conceive more quickly
PGT-A testing is performed on embryos created through an IVF cycle. After fertilization occurs and embryos have the chance to grow for several days to reach a stage of development called blastocysts, the lab obtains a small number of cells from a part of the blastocyst called the trophectoderm, which would eventually form the placenta. Our genetics lab partner then examines the number of each embryo’s chromosomes.
If you are interested in PGT-A, discuss it with your Financial Coordinator to understand whether you might incur additional out-of-pocket costs.
PGT-A has 98% accuracy in detecting major chromosome abnormalities
Approximately 50% of miscarriages occur due to chromosomal abnormalities
Male factor infertility (including abnormal quantity and quality of sperm) can increase the risk of chromosomal abnormalities in the embryo
PGT-A can identify embryos that have disorders relating to their number of chromosomes, which occur randomly and with greater frequency as we age
Preimplantation genetic testing for monogenic defects (PGT-M) looks for a specific single gene mutation in embryos. While PGT-M is not necessary for all patients, it is an invaluable service for those who are carriers of a genetic disorder because it can ensure that the embryo selected for transfer will not be affected by that disorder.
✓ PGT-M has a 98% accuracy rate in detecting major chromosome abnormalities
✓ PGT-M can now be performed for most known single gene disorders.
✓ PGT-A is always performed in tandem with PGT-M, which provides prospective parents with even more information about the genetic makeup of their embryos
If PGT-M is important to you, discuss it with your Financial Coordinator as there may be additional out-of-pocket costs.
✓ You or your partner have a family history of genetic disorders, including cystic fibrosis, fragile-X syndrome, spinal muscular atrophy, or more than 250 others
✓ You or your partner have an elevated risk of passing on a specific single gene disorder
As with PGT-A testing, PGT-M testing is performed on embryos created through an IVF cycle. After fertilization occurs and embryos have the chance to grow for several days to a developmental stage called blastocysts, the lab obtains a small number of cells from a part of each blastocyst called the trophectoderm, which would eventually form the placenta. From these biopsies, Boston IVF’s collaborating genetic laboratories can test for more than 250 different single gene disorders.
PGT-M is an invaluable service for those who are carriers of a genetic disorder
PGT-M has a 98% accuracy rate in detecting major chromosome abnormalities
PGT-M can test for more than 250 different single gene disorders
PGT-A is always performed in tandem with PGT-M for enhanced genetic insights
Wherever you are in your fertility journey, we look forward to being part of your story.
Pursuing assisted reproductive technologies to build your family can be full of uncertainty. We’re always here, and we’re always happy to help.